Literature DB >> 15016758

Genetics of liver disease: immunogenetics and disease pathogenesis.

P T Donaldson1.   

Abstract

Understanding the genetic basis of "complex disease" has been heralded as one of the major challenges of the post genome era. However what are "complex diseases" and how will understanding the genetics of such diseases advance medical science? There has been a great deal of "hype" about the potential of the human genome mapping project. The three major claims are that this information will: (a) be used in diagnosis; (b) provide useful prognostic indices for disease management (including the development of individualised treatment regimens, based on the findings of both immunogenetic and pharmacogenetic studies); and (c) provide insight into the pathogenesis of these diseases. Of these three objectives the last has the greatest potential and is the least exaggerated claim. In this review I shall highlight major associations, discuss some of the practical issues that arise, and outline how current knowledge of the immunogenetic basis of chronic liver disease is beginning to inform the debate about disease pathogenesis.

Entities:  

Mesh:

Year:  2004        PMID: 15016758      PMCID: PMC1773998          DOI: 10.1136/gut.2003.031732

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  41 in total

1.  Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.

Authors:  Hironori Ueda; Joanna M M Howson; Laura Esposito; Joanne Heward; Hywel Snook; Giselle Chamberlain; Daniel B Rainbow; Kara M D Hunter; Annabel N Smith; Gianfranco Di Genova; Mathias H Herr; Ingrid Dahlman; Felicity Payne; Deborah Smyth; Christopher Lowe; Rebecca C J Twells; Sarah Howlett; Barry Healy; Sarah Nutland; Helen E Rance; Vin Everett; Luc J Smink; Alex C Lam; Heather J Cordell; Neil M Walker; Cristina Bordin; John Hulme; Costantino Motzo; Francesco Cucca; J Fred Hess; Michael L Metzker; Jane Rogers; Simon Gregory; Amit Allahabadia; Ratnasingam Nithiyananthan; Eva Tuomilehto-Wolf; Jaakko Tuomilehto; Polly Bingley; Kathleen M Gillespie; Dag E Undlien; Kjersti S Rønningen; Cristian Guja; Constantin Ionescu-Tîrgovişte; David A Savage; A Peter Maxwell; Dennis J Carson; Chris C Patterson; Jayne A Franklyn; David G Clayton; Laurence B Peterson; Linda S Wicker; John A Todd; Stephen C L Gough
Journal:  Nature       Date:  2003-04-30       Impact factor: 49.962

Review 2.  Genetics in autoimmune hepatitis.

Authors:  Peter T Donaldson
Journal:  Semin Liver Dis       Date:  2002-11       Impact factor: 6.115

Review 3.  Problems of reporting genetic associations with complex outcomes.

Authors:  Helen M Colhoun; Paul M McKeigue; George Davey Smith
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

4.  Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease.

Authors:  K Hata; D H Van Thiel; R B Herberman; T L Whiteside
Journal:  Hepatology       Date:  1992-05       Impact factor: 17.425

Review 5.  Genetic factors in the pathogenesis of primary biliary cirrhosis.

Authors:  David E J Jones; Peter T Donaldson
Journal:  Clin Liver Dis       Date:  2003-11       Impact factor: 6.126

6.  Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.

Authors:  S Knapp; L J Yee; A J Frodsham; B J W Hennig; S Hellier; L Zhang; M Wright; M Chiaramonte; M Graves; H C Thomas; A V S Hill; M R Thursz
Journal:  Genes Immun       Date:  2003-09       Impact factor: 2.676

7.  Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population.

Authors:  Zhifeng Zhou; Xing-Yu Lin; Pradip N Akolkar; Beena Gulwani-Akolkar; Jeremiah Levine; Seymour Katz; Jack Silver
Journal:  Am J Gastroenterol       Date:  2002-12       Impact factor: 10.864

8.  Association of CTLA4 polymorphisms with sustained response to interferon and ribavirin therapy for chronic hepatitis C virus infection.

Authors:  Leland J Yee; Kevin A Perez; Jianming Tang; Dirk J van Leeuwen; Richard A Kaslow
Journal:  J Infect Dis       Date:  2003-04-02       Impact factor: 5.226

9.  Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis.

Authors:  Peter T Donaldson; Suzanne Norris
Journal:  Autoimmunity       Date:  2002-12       Impact factor: 2.815

10.  Does a betaretrovirus infection trigger primary biliary cirrhosis?

Authors:  Lizhe Xu; Zhiwei Shen; Linsheng Guo; Brent Fodera; Adrian Keogh; Ruth Joplin; Barbara O'Donnell; James Aitken; William Carman; James Neuberger; Andrew Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-27       Impact factor: 12.779

View more
  32 in total

1.  Preempting and preventing drug-induced liver injury.

Authors:  Guruprasad P Aithal; Ann K Daly
Journal:  Nat Genet       Date:  2010-08       Impact factor: 38.330

Review 2.  Immunopathogenesis of primary sclerosing cholangitis.

Authors:  Joy Worthington; Sue Cullen; Roger Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

Review 3.  Etiopathogenesis of primary sclerosing cholangitis.

Authors:  Roger Chapman; Sue Cullen
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

4.  Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes.

Authors:  Jennifer Guy; Marion G Peters
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-10

Review 5.  Pathogens and autoimmune hepatitis.

Authors:  U Christen; E Hintermann
Journal:  Clin Exp Immunol       Date:  2018-10-07       Impact factor: 4.330

Review 6.  Cutting edge issues in autoimmune hepatitis.

Authors:  Diego Vergani; Giorgina Mieli-Vergani
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

Review 7.  Update on inflammatory bowel disease in patients with primary sclerosing cholangitis.

Authors:  Christos Tsaitas; Anysia Semertzidou; Emmanouil Sinakos
Journal:  World J Hepatol       Date:  2014-04-27

Review 8.  Autoimmune hepatitis.

Authors:  Diego Vergani; Maria Serena Longhi; Dimitrios P Bogdanos; Yun Ma; Giorgina Mieli-Vergani
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

Review 9.  Mechanisms of tissue injury in autoimmune liver diseases.

Authors:  Evaggelia Liaskou; Gideon M Hirschfield; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2014-08-01       Impact factor: 9.623

10.  Medullary thymic epithelial cell depletion leads to autoimmune hepatitis.

Authors:  Anthony J Bonito; Costica Aloman; M Isabel Fiel; Nichole M Danzl; Sungwon Cha; Erica G Weinstein; Seihwan Jeong; Yongwon Choi; Matthew C Walsh; Konstantina Alexandropoulos
Journal:  J Clin Invest       Date:  2013-07-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.